Activation of non-classical monocytes through CX3CR1 leads to the upregulation of CCL3, CCL4, and CCL5 chemokines, resulting in the recruitment and activation of anti-tumoral NK cells, which contribute to cancer cell death, while this monocyte subset is not able to directly kill tumor cells [60,61]. Here, CX3CR1 is linked to neoplasm.